- Home
- SYBX vs TRAW Comparison
SYBX vs TRAW Comparison
Compare SYBX & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- TRAW
- Stock Information
- Founded
- SYBX N/A
- TRAW 1998
- Country
- SYBX United States
- TRAW United States
- Employees
- SYBX N/A
- TRAW N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- TRAW
- Sector
- SYBX Health Care
- TRAW
- Exchange
- SYBX Nasdaq
- TRAW NYSE
- Market Cap
- SYBX 15.9M
- TRAW 15.0M
- IPO Year
- SYBX N/A
- TRAW 2013
- Fundamental
- Price
- SYBX $1.44
- TRAW $4.48
- Analyst Decision
- SYBX Buy
- TRAW
- Analyst Count
- SYBX 4
- TRAW 0
- Target Price
- SYBX $15.50
- TRAW N/A
- AVG Volume (30 Days)
- SYBX 11.6K
- TRAW 8.3K
- Earning Date
- SYBX 11-12-2024
- TRAW 11-14-2024
- Dividend Yield
- SYBX N/A
- TRAW N/A
- EPS Growth
- SYBX N/A
- TRAW N/A
- EPS
- SYBX N/A
- TRAW N/A
- Revenue
- SYBX $2,777,000.00
- TRAW $226,000.00
- Revenue This Year
- SYBX N/A
- TRAW $2.90
- Revenue Next Year
- SYBX N/A
- TRAW N/A
- P/E Ratio
- SYBX N/A
- TRAW N/A
- Revenue Growth
- SYBX 292.23
- TRAW N/A
- 52 Week Low
- SYBX $1.22
- TRAW $4.16
- 52 Week High
- SYBX $5.12
- TRAW $27.50
- Technical
- Relative Strength Index (RSI)
- SYBX 52.54
- TRAW 33.99
- Support Level
- SYBX $1.37
- TRAW $4.92
- Resistance Level
- SYBX $1.42
- TRAW $5.96
- Average True Range (ATR)
- SYBX 0.08
- TRAW 0.33
- MACD
- SYBX -0.00
- TRAW -0.01
- Stochastic Oscillator
- SYBX 29.24
- TRAW 18.00
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.